Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,853
Closed -$2.2M 27
2022
Q4
$2.2M Hold
10,853
1.76% 22
2022
Q3
$1.91M Sell
10,853
-243
-2% -$49.7K 1.64% 24
2022
Q2
$2.23M Sell
11,096
-83
-0.7% -$17.7K 1.78% 21
2022
Q1
$2.61M Sell
11,179
-147
-1% -$34.6K 1.82% 21
2021
Q4
$2.61M Hold
11,326
2.23% 20
2021
Q3
$2.74M Sell
11,326
-85
-0.7% -$21.4K 2.08% 21
2021
Q2
$2.7M Sell
11,411
-229
-2% -$52.2K 1.79% 22
2021
Q1
$2.55M Buy
+11,640
New +$2.34M 1.79% 23

Other funds holding LH

XXEC Inc's LH Position: Q1 2023 in Review

XXEC Inc sold out of Labcorp (LH) in Q1 2023, closing a stake of 10,853 shares — an estimated $2.2M sold.

XXEC Inc first reported a position in LH in Q1 2021 and held it in 8 quarters. The position peaked at $2.74M in Q3 2021. 941 funds tracked by Wall St. Rank hold LH as of Q1 2023.

  • XXEC Inc reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
  • XXEC Inc sold 10,853 Labcorp shares in Q1 2023, an estimated $2.2M.
  • XXEC Inc first reported a position in Labcorp in Q1 2021 and held it in 8 quarters.
  • XXEC Inc's Labcorp position peaked at $2.74M in Q3 2021.
  • 941 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on XXEC Inc's 13F filing for Q1 2023, filed 8 May 2023.